JFG
ABBV icon

Jefferies Financial Group’s AbbVie ABBV Stock Holding History

Jefferies Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.3M Buy
208,359
+104,902
+101% +$23.3M 0.31% 49
2025
Q4 		$23.6M Buy
103,457
+3,784
+4% +$862K 0.12% 170
2025
Q3 		$23.1M Sell
99,673
-53,123
-35% -$10.8M 0.11% 141
2025
Q2 		$28.4M Sell
152,796
-26,832
-15% -$4.99M 0.24% 86
2025
Q1 		$37.6M Buy
179,628
+122,214
+213% +$23.8M 0.33% 49
2024
Q4 		$10.2M Sell
57,414
-246,037
-81% -$45.2M 0.06% 220
2024
Q3 		$59.9M Buy
303,451
+23,730
+8% +$4.43M 0.43% 34
2024
Q2 		$48M Buy
279,721
+216,167
+340% +$35.8M 0.51% 27
2024
Q1 		$11.6M Buy
+63,554
New +$11M 0.11% 149
2023
Q4 		– Sell
-19,562
Closed -$2.92M – 1644
2023
Q3 		$2.92M Sell
19,562
-1,078
-5% -$158K 0.03% 497
2023
Q2 		$2.78M Sell
20,640
-136,480
-87% -$20M 0.02% 545
2023
Q1 		$25M Buy
157,120
+66,801
+74% +$10.2M 0.2% 83
2022
Q4 		$14.6M Buy
+90,319
New +$13.8M 0.1% 162
2019
Q2 		– Sell
-17,028
Closed -$1.37M – 14
2019
Q1 		$1.37M Sell
17,028
-23,777
-58% -$1.95M 0.14% 20
2018
Q4 		$3.76M Buy
40,805
+725
+2% +$63.8K 0.44% 15
2018
Q3 		$3.79M Buy
40,080
+7,551
+23% +$716K 0.31% 40
2018
Q2 		$3.01M Buy
+32,529
New +$3.18M 0.23% 47
2018
Q1 		– Sell
-5,109
Closed -$494K – 75
2017
Q4 		$494K Buy
+5,109
New +$481K 0.04% 67
2017
Q2 		– Sell
-8,008
Closed -$522K – 55
2017
Q1 		$522K Buy
+8,008
New +$503K 0.04% 46

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jefferies Financial Group's ABBV Position: Q1 2026 in Review

Jefferies Financial Group increased its AbbVie (ABBV) stake by 101% in Q1 2026, buying an estimated $23.3M and bringing the position to 208,359 shares worth $45.3M. The position accounts for 0.31% of the portfolio, ranked #49.

Jefferies Financial Group first reported a position in ABBV in Q1 2017 and has held it in 19 quarters since. The position peaked at $59.9M in Q3 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Jefferies Financial Group held 208,359 shares of AbbVie worth $45.3M as of Q1 2026.
  • Jefferies Financial Group bought 104,902 AbbVie shares in Q1 2026, an estimated $23.3M.
  • AbbVie made up 0.31% of Jefferies Financial Group's portfolio in Q1 2026, its #49 holding.
  • Jefferies Financial Group first reported a position in AbbVie in Q1 2017 and has held it in 19 quarters since.
  • Jefferies Financial Group's AbbVie position peaked at $59.9M in Q3 2024.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.